HOF Capital — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
Toronto
Darren Fung(Executive Officer, Director)Win Bear(Director)Brian Sinclair(Director)Derrick Fung(Executive Officer, Director)Paul Crowe(Executive Officer)Cameron Dearsley(Executive Officer)
Board seatOnsi Sawiris· per SEC Form D · $17.6M raise · filed Mar 2022
Postera uses artificial intelligence and computational chemistry to accelerate drug discovery for pharmaceutical companies.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesBoston, US
Aaron Morris(Founder)inAlpha Lee(Founder)inMatthew Robinson(Founder)in
Co-investorsBreyer CapitalLifeforce CapitalMetaplanetY CombinatorACE & Company
Teiko provides CLIA-validated high-dimensional cytometry services—including spectral flow and mass cytometry panels, blood preservation kits, gating, and a data analysis dashboard—for immune cell profiling in clinical trials.
BiotechDigital HealthHealthtechSalt Lake City, US
Ramji Srinivasan(Executive Officer, Director)inMatt(Co-founder)inMatthew Spitzer(Director)
BoardVictor Wang(Director)in
Co-investorsCivilization Ventures Management, LlcHAWKTAILTau VenturesTwine VenturesWestern Technology Investment
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.